Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 291 trials across Europe, recruiting first
Study on Selexipag and Bosentan for Children with Pulmonary Arterial Hypertension
BelgiumStudy Comparing Dupilumab and Mepolizumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Danish Patients
DenmarkStudy on the Safety of Ceftolozane and Tazobactam for Children with Hospital-Acquired Pneumonia
EstoniaStudy of Datopotamab Deruxtecan and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with Low PD-L1 Levels
AustriaStudy Comparing Subcutaneous Pembrolizumab with Hyaluronidase to Intravenous Pembrolizumab and Chemotherapy for First-line Treatment of Metastatic Non-Small Cell Lung Cancer
FranceStudy of Nivolumab and Ipilimumab for Patients with Stage 3 Non-Small Cell Lung Cancer Not Suitable for Surgery
BelgiumStudy on the Effectiveness and Safety of Benralizumab for Children with Severe Eosinophilic Asthma
FranceStudy Comparing Nivolumab with Ipilimumab or Nivolumab with Chemotherapy to Chemotherapy Alone in Patients with Early Stage Non-Small Cell Lung Cancer
FranceStudy on the Effects of S-217622 for Adults Hospitalized with COVID-19
DenmarkStudy on the Effectiveness and Safety of Imipenem, Cilastatin, and XNW4107 for Adults with Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia
FranceStudy of 68Ga Satoreotide Trizoxetan PET/CT in Patients with High-Grade Neuroendocrine Lung Cancer
DenmarkContinued Treatment Study for Patients with Myelofibrosis, Post-Lung Transplant BOS, or Chronic Graft-Versus-Host Disease Using Itacitinib
AustriaThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
